Cidel Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Sell
18,925
-727
-4% -$85.1K 0.12% 104
2026
Q1
$2.36M Buy
19,652
+2,592
+15% +$299K 0.13% 95
2025
Q4
$1.8M Buy
17,060
+307
+2% +$28.8K 0.13% 97
2025
Q3
$1.41M Buy
16,753
+1,682
+11% +$139K 0.08% 106
2025
Q2
$1.19M Buy
15,071
+2,191
+17% +$174K 0.07% 110
2025
Q1
$1.16M Buy
12,880
+1,566
+14% +$146K 0.08% 106
2024
Q4
$1.13M Buy
11,314
+785
+7% +$80.9K 0.08% 106
2024
Q3
$1.2M Buy
10,529
+363
+4% +$43.1K 0.08% 103
2024
Q2
$1.26M Buy
10,166
+246
+2% +$31.7K 0.1% 94
2024
Q1
$1.31M Hold
9,920
0.1% 92
2023
Q4
$1.08M Buy
+9,920
New +$1.03M 0.05% 108
2019
Q2
Sell
-4,688
Closed -$372K 128
2019
Q1
$372K Sell
4,688
-419
-8% -$31.3K 0.02% 98
2018
Q4
$372K Buy
5,107
+419
+9% +$29.6K 0.02% 77
2018
Q3
$317K Hold
4,688
0.01% 83
2018
Q2
$272K Buy
+4,688
New +$264K 0.01% 89

Other funds holding MRK

Cidel Asset Management's MRK Position: Q2 2026 in Review

Cidel Asset Management reduced its Merck (MRK) stake by 3.7% in Q2 2026, selling an estimated $85.1K and leaving 18,925 shares worth $2.43M. The position accounts for 0.12% of the portfolio, ranked #104.

Cidel Asset Management first reported a position in MRK in Q2 2018 and has held it in 15 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cidel Asset Management held 18,925 shares of Merck worth $2.43M as of Q2 2026.
  • Cidel Asset Management sold 727 Merck shares in Q2 2026, an estimated $85.1K.
  • Merck made up 0.12% of Cidel Asset Management's portfolio in Q2 2026, its #104 holding.
  • Cidel Asset Management first reported a position in Merck in Q2 2018 and has held it in 15 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.